Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease
Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease is organized by American Academy of Neurology (AAN).
The American Academy of Neurology designates that participants earn 0.5 AMA PRA Category 1 CME Credits™ for completion of each multiple-choice podcast exam. Physicians should only claim credit commensurate with the extent of their participation in the activity. CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.
Upon completion of this podcast, participants will be able to understand that first ruling out PMP22 duplication/deletion, then considering a targeted genetic testing approach as outlined, in selected patients will increase diagnostic yield in Charcot-Marie-Tooth disease.
- CME : 0.5
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
Number of Health Care Professionals Registered: 2 Number
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes